Press releases

Baxter Healthcare’s $2.5m compounding facility opens at the Australian Cancer Centre  

The Hon. John Hill, MP, Minister for Health has today officially opened a new $2.5 million compounding pharmacy facility, which will supply chemotherapy and IV nutritional products to patients throughout South Australia.

The TGA accredited facility is operated by Baxter Healthcare Pty Ltd who has been supplying the much needed medications and therapies in Australia for over 20 years.  The company's latest investment, employs close to 20 people, is located within the Australian Cancer Centre and can service all public and private hospitals within South Australia.

David Akeroyd, Managing Director Baxter ANZ says: "compounding cancer medications and nutrition therapies is one of our core competencies.  This new facility will allow us to service hospitals in SA better, with faster turnaround times for Oncologists, Pharmacists and patients."

Baxter Pharmacy Services is the first fully TGA licensed facility in South Australia capable of providing a complete range of aseptically compounded IV preparations, including cytotoxic (chemotherapy), analgesic, antibiotic and IV parenteral nutrition solutions

ABOUT BAXTER'S COMPOUNDING PHARMACIES
Baxter provides TGA regulated aseptic compounding services, Baxter Pharmacy Services, for hospital pharmacies Australia wide.   Products include chemotherapy, antibiotics, analgesics for pain relief and intravenous nutrition.

Baxter is the recognised leader in this specialised manufacturing field having provided this service in Australia since 1983.

Approximately 300 pharmacy staff are employed by Baxter across Australia and New Zealand in eight compounding facilities. All of Baxter's facilities are TGA/Medsafe approved and audited.
Baxter's local manufacturing capabilities play an integral role in the provision of life saving products and services across ANZ.

BACKGROUND

BAXTER  PHARMACY SERVICES - ADELAIDE
Investment: $AUD2.5 million

• Centre will employ 16 full time pharmacists and pharmacy technicians
• First and only fully TGA licensed facility in SA capable of providing a complete range of aseptically compounded IV preparations, including cytotoxic, analgesic, antibiotic and parenteral nutrition solutions
• Facility will feature 5 Cytotoxic Drug Safety Cabinets (CDSC's) and 3 Laminar Flow cabinets (LAF's)
• Capable of servicing entire SA patient population
• Co-located within the Tennyson Centre, Adelaide's brand new specialist cancer treatment centre
• The facility represents a continuing commitment to the health of South Australians, helping to ensure that the growing needs of both Oncologists, Pharmacists and patients are fully met.
• Also providing options and quality alternatives to support the growing move towards home based therapies